NT-002

N/A

Report date: 2023/06/07 20:00:31

Base Information

Drug NameNT-002
Drug Alias NameNT-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperparathyroidism, SecondaryKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEirgen Pharma LtdNicoya Therapeutics (Shanghai) Co LtdCatalent Pharma Solutions LLC
China Registration ClassN/A

Develop Information

Active CompaniesEirgen Pharma LtdNicoya Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, SecondaryKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A